BRCA1 and breast carcinoma: Conversely, an interaction between rs299290 and rs11649877 (3’ region of TUBG1) could increase breast cancer risk in both BRCA1 and BRCA2 mutation carriers (HRs = 1.33 and 1.21, respectively; Table 1).